South Korea Viral Gene Therapy Market was valued at USD 0.50 Billion in 2022 and is projected to reach USD 1.20 Billion by 2030, growing at a CAGR of 11.8% from 2024 to 2030.
The South Korea Viral Gene Therapy Market is experiencing rapid growth as biotechnology advancements propel the nation toward becoming a leader in the field. Viral gene therapy utilizes modified viruses to deliver therapeutic genes into cells, aiming to treat genetic disorders and diseases that currently have no cure. This breakthrough in medicine is not only capturing the attention of the pharmaceutical industry but is also being embraced by a variety of other sectors that require innovative solutions for disease management and treatment. The demand for such therapies is expected to surge as South Korea continues to invest in cutting-edge research and development.
One of the primary drivers of this growth is the need for more effective treatments in the healthcare industry. Genetic diseases such as hemophilia, cystic fibrosis, and certain cancers are some of the targets for viral gene therapy, with clinical trials showing promising results. The market is also being influenced by the increasing number of biotechnology companies in South Korea, which are pushing the boundaries of what is possible in gene therapy. The government's strong focus on health technology innovation and favorable regulations further accelerate progress, providing a solid foundation for viral gene therapy research and commercialization.
Additionally, the pharmaceutical industry requires viral gene therapy for improving targeted treatments, reducing drug side effects, and offering patients more personalized care. South Korean companies are capitalizing on this demand by collaborating with global partners, sharing expertise, and combining resources to bring these therapies to market faster. Moreover, the biopharmaceutical sector is benefiting from the high demand for gene-editing technologies such as CRISPR, which is used in conjunction with viral vectors to modify genes at precise locations.
Another factor contributing to the viral gene therapy market's expansion is the growing interest from industries outside of healthcare. For instance, the agricultural sector is beginning to explore the use of gene therapy to improve crop resistance to pests and diseases. Even the cosmetic industry has begun to look at the potential of gene therapy in rejuvenating skin cells and reversing the signs of aging. These industries, too, will rely heavily on the viral gene therapy market as they work to develop innovative products that address consumer needs.
In summary, the South Korea Viral Gene Therapy Market is poised for tremendous growth as various industries recognize the potential applications of gene therapy. With a strong foundation in research and development, the country is well-positioned to lead the way in this rapidly evolving market.
Get an In-Depth Research Analysis of the South Korea Viral Gene Therapy Market Size And Forecast [2025-2032]
Â
Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Viral Gene Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Viral Gene Therapy Market
Adenoviral Vectors
Retroviral Vectors
Adeno-Associated Viral Vectors (AAV)
Lentiviral Vectors
Other Viral Vectors
Oncolytic Viral Therapy
Gene Replacement Therapy
Gene Editing Therapy
Immunotherapy
Other Therapeutic Approaches
Oncology
Cardiovascular Diseases
Neurological Disorders
Genetic Disorders
Infectious Diseases
Other Applications
Hospitals and Clinics
Research Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
In vivo Delivery
Ex vivo Delivery
Intravenous Route
Intramuscular Route
Intrathecal Route
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Viral Gene Therapy Market Research Analysis
1. Introduction of the South Korea Viral Gene Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Viral Gene Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Viral Gene Therapy Market, By Type
6. South Korea Viral Gene Therapy Market, By Application
7. South Korea Viral Gene Therapy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Viral Gene Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/